Malcolm W. R. Reed

researcher

Malcolm W. R. Reed is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0001-7442-2132
P2038ResearchGate profile IDMalcolm_Reed
P1153Scopus author ID57202213914
P214VIAF ID103816708
P7859WorldCat Identities ID (superseded)lccn-nb2010008760

P108employerUniversity of SheffieldQ823917
P735given nameMalcolmQ6584302
MalcolmQ6584302
P106occupationresearcherQ1650915
oncologistQ16062369
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q3587156719p13.1 is a triple-negative-specific breast cancer susceptibility locus
Q360214067q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium
Q371698739q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Q37052173A BCL2 promoter polymorphism rs2279115 is not associated with BCL2 protein expression or patient survival in breast cancer patients
Q37313778A breast cancer risk haplotype in the caspase-8 gene
Q57250674A common coding variant in CASP8 is associated with breast cancer risk
Q37534963A critical analysis of current in vitro and in vivo angiogenesis assays
Q37619303A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Q44385739A naturally occurring mutation in an ATP-binding domain of the recombination repair gene XRCC3 ablates its function without causing cancer susceptibility
Q48303260A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer
Q37599352A role for XRCC2 gene polymorphisms in breast cancer risk and survival
Q47385333Addressing overtreatment of screen detected DCIS; the LORIS trial
Q92252577Adjuvant Chemotherapy for Breast Cancer in Older Women: An Analysis of Retrospective English Cancer Registration Data
Q72795362Advanced gastrointestinal malignancy or benign inflammatory disease? An unusual presentation of sclerosing mesenteritis. Report of a case
Q79085503An audit of the management of soft tissue sarcoma within a health region in the UK
Q49058397Angiogenesis induction and regression in human surgical wounds.
Q84384562Angiosarcoma
Q34613673Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Q38711330Assessing medical student knowledge and attitudes about shared decision making across the curriculum: protocol for an international online survey and stakeholder analysis.
Q46247407Assessing the functional role of caspase-8 gene variants in breast cancer.
Q33828680Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival
Q45188733Association of a common variant of the CASP8 gene with reduced risk of breast cancer
Q36981021Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer
Q35022847Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies
Q35532898Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Q52003179Assuring the quality of high-stakes undergraduate assessments of clinical competence.
Q35601690Audit of compliance to adjuvant chemotherapy and radiotherapy guidelines in breast cancer in a cancer network
Q30239832Axillary treatment for operable primary breast cancer.
Q52838816Axillary treatment in women with one or two sentinel nodes with macrometastases: more evidence is needed to inform practice.
Q51917785Breast cancer follow-up: could primary care be the right venue?
Q34327945Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
Q96132023Breast cancer surgery in older women: outcomes of the Bridging Age Gap in Breast Cancer study
Q96825417Bridging the Age Gap: a prognostic model that predicts survival and aids in primary treatment decisions for older women with oestrogen receptor-positive early breast cancer
Q102318444Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life
Q42697893Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial
Q36449203CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer
Q37368484Case report: the ultrasound and Doppler appearances of pelvic varices
Q51646130Characterisation of an experimental model of chronic lower limb ischaemia in the anaesthetised rat.
Q51465348Common duct diameter as an independent predictor of choledocholithiasis: is it useful?
Q43274554Common genetic changes in leiomyosarcoma and gastrointestinal stromal tumour: implication for ataxia telangiectasia mutated involvement
Q35794653Common germline polymorphisms associated with breast cancer-specific survival
Q34379032Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q49560395Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial.
Q44302616Copper Deficiency Alters Vasodilation in the Rat Cremaster Muscle Microcirculation
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q38088366Current status and future prospects for anti-angiogenic therapies in cancer.
Q84526802Cutaneous angiosarcoma after breast conserving treatment for bilateral breast cancers in a BRCA-1 gene mutation carrier--a case report and review of the literature
Q33412299Description and reporting of surgical data--scope for improvement?
Q36918154Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus
Q50530596Does Changing Examiner Stations During UK Postgraduate Surgery Objective Structured Clinical Examinations Influence Examination Reliability and Candidates' Scores?
Q77621329Drilling efficiency and temperature elevation of three types of Kirschner-wire point
Q48264790Dyspraxia in clinical education: a review
Q51383601Effects of chronic administration of Helicobacter pylori extracts on rat gastric mucosal microcirculation in vivo.
Q33181821Effects of genotypically different strains of Helicobacter pylori on human microvascular endothelial cells in vitro.
Q51667177Effects of sedation and supplemental oxygen during upper alimentary tract endoscopy.
Q61449015Efficient development and usability testing of decision support interventions for older women with breast cancer
Q33288626Endostatin gene variation and protein levels in breast cancer susceptibility and severity
Q57250672Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk
Q38737950Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines.
Q50973788Evaluation of fluorescent plasma markers for in vivo microscopy of the microcirculation.
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q35661406Fine-mapping CASP8 risk variants in breast cancer
Q35524465Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Q34903062Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Q37367871Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Q34979715Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
Q35151684Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q34378972Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q35996692Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Q24622610Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Q24645441Genome-wide association study identifies novel breast cancer susceptibility loci
Q50899464Healthcare professionals' preferences for surgery or primary endocrine therapy to treat older women with operable breast cancer.
Q36276540Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Q33330850Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
Q28485381High quality genomic copy number data from archival formalin-fixed paraffin-embedded leiomyosarcoma: optimisation of universal linkage system labelling
Q92771850Human factors in medicine: the art of common sense at work
Q35102646Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Q36014067Identification of novel genetic markers of breast cancer survival
Q67959467Importance of light dose in fluorescent microscopy
Q47333386Information needs and decision-making preferences of older women offered a choice between surgery and primary endocrine therapy for early breast cancer
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q33250259Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review.
Q40460962Intestinal endometriosis: presentation, investigation, and surgical management.
Q34898735Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
Q37452183Is nitric oxide important in photodynamic therapy?
Q29416989Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Q35119701Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Q37999119Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA).
Q49485930Mastectomy for risk reduction or symmetry in women without high risk gene mutation: A review.
Q47269753Matrix metalloproteinase activity and immunohistochemical profile of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 during human dermal wound healing
Q51407477Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo.
Q91335254Medical Students' Knowledge and Attitudes Toward Shared Decision Making: Results From a Multinational, Cross-Sectional Survey
Q34497352MicroRNA related polymorphisms and breast cancer risk
Q34123806Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls
Q39668509Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and Wales.
Q102073408National inter-rater agreement of standardised simulated-patient-based assessments
Q46792535Neuropilin-1 and neuropilin-2 expression in the adenoma-carcinoma sequence of colorectal cancer
Q37356243Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Q30374367No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Q53082925Offering informed choice about breast screening.
Q88780519Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer-specific survival
Q57299103Opportunities and priorities for breast surgical research
Q28584533PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Q36873786Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q38202258Primary endocrine therapy as a treatment for older women with operable breast cancer - a comparison of randomised controlled trial and cohort study findings.
Q67966189Prostanoid antagonists inhibit the response of the microcirculation to "early" photodynamic therapy
Q35968721Publication of surgical abstracts in full text: a retrospective cohort study
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q50165876Randomised, prospective, single-blind comparison of laparoscopic versus small-incision cholecystectomy.
Q35155449Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Q37300024Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Q24806157Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity
Q35994724Short-term dietary copper deficiency does not inhibit angiogenesis in tumours implanted in striated muscle
Q61804345Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study
Q55003989Sister Chromatid Exchange and Genomic Instability in Soft Tissue Sarcomas: Potential Implications for Response to DNA-Damaging Treatments.
Q33593016Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies
Q96223495The Carbon Footprint of Surgical Operations: A Systematic Review
Q36023363The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer
Q100751136The care of older cancer patients in the United Kingdom
Q42280945The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo
Q42204434The effect of photodynamic therapy on the microcirculation
Q34449139The history of photodetection and photodynamic therapy.
Q67903315The influence of photodynamic therapy on the ultrastructure of the normal rat bladder
Q69682976The rat urinary bladder: vasoactivity and macromolecular leakage in a new model
Q41017408The relationship between semaphorin 3C and microvessel density in the progression of breast and oral neoplasia
Q36142060The role of genetic breast cancer susceptibility variants as prognostic factors
Q35092939The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis
Q37122001Tissue factor, angiogenesis and tumour progression
Q37967810Transforming Growth Factor-β and Endoglin Signaling Orchestrate Wound Healing
Q35658679Understanding older women's decision making and coping in the context of breast cancer treatment
Q39061298Vascular-targeted agents for the treatment of angiosarcoma
Q47977122What influences healthcare professionals' treatment preferences for older women with operable breast cancer? An application of the discrete choice experiment.

Search more.